comparemela.com

Research analysts at StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance GLMD remained flat at $0.39 during trading on Thursday. The company had a […]

Related Keywords

,Galmed Pharmaceuticals Stock Performance ,Galmed Pharmaceuticals ,News Ratings For Galmed Pharmaceuticals Daily ,Galmed Pharmaceuticals Ltd ,Get Free Report ,Pharmaceuticals Ltd ,Galmed Pharmaceuticals Daily ,Nasdaq Glmd ,Glmd ,Medical ,Initiated Coverage ,Stocknews Com ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.